SCHEMBL14033946

SCHEMBL14033946

CCN1C(=O)c2c(O)c3c(n2CC12CC2)CCN(Cc1ccc(F)cc1)C3=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.36
KCNH2 Q12809 1/20 0.35
GRM2 Q14416 1/20 0.35
LMNA P02545 6/20 0.35
SMN1; SMN2 Q16637 4/20 0.35
OPRM1 P35372 4/20 0.35
OPRL1 P41146 4/20 0.35
HTT P42858 3/20 0.35
L3MBTL1 Q9Y468 3/20 0.35
ALDH1A1 P00352 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
TDP1 Q9NUW8 1/20 0.34
POLB P06746 1/20 0.34
TP53 P04637 1/20 0.33
NCOA3 Q9Y6Q9 1/20 0.33
HDAC3 O15379 1/20 0.32
HDAC4 P56524 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC7 Q8WUI4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4748607 0.89 AKR1B1 (0.36) AKR1B1KCNH2GRM2LMNASMN1; SMN2
SCHEMBL14034164 0.82 AKR1B1 (0.39) AKR1B1KCNH2GRM2LMNASMN1; SMN2
SCHEMBL4750297 0.82 KCNH2 (0.43) AKR1B1KCNH2GRM2LMNASMN1; SMN2
SCHEMBL4743177 0.80 TP53 (0.35) AKR1B1KCNH2GRM2LMNASMN1; SMN2
SCHEMBL5126325 0.80 KCNH2 (0.47) AKR1B1KCNH2GRM2LMNASMN1; SMN2
SCHEMBL4754316 0.79 CLPP (0.33) AKR1B1KCNH2GRM2KMT2A
SCHEMBL4744312 0.79 KCNH2 (0.41) AKR1B1KCNH2GRM2LMNASMN1; SMN2
SCHEMBL4751078 0.78 GRM2 (0.36) AKR1B1KCNH2GRM2LMNASMN1; SMN2
SCHEMBL4751130 0.77 ALDH1A1 (0.43) LMNASMN1; SMN2HTTL3MBTL1ALDH1A1
SCHEMBL4744307 0.75 GRM2 (0.38) AKR1B1KCNH2GRM2LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7435735-B2 Hydroxy pyridopyrrolopyrazine dione compounds useful as HIV integrase inhibitors MERCK & CO., INC. (US) 2008-10-14 US disclosed
US-7435735-B2 Hydroxy pyridopyrrolopyrazine dione compounds useful as HIV integrase inhibitors MERCK & CO., INC. (US) 2008-10-14 US disclosed
US-20070093496-A1 Hydroxy pyridopyrrolopyrazine dione compounds useful as hiv integrase inhibitors MERCK SHARP & DOHME CORP. 2007-04-26 US disclosed
US-20070093496-A1 Hydroxy pyridopyrrolopyrazine dione compounds useful as hiv integrase inhibitors MERCK SHARP & DOHME CORP. 2007-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070093496-A1 Hydroxy pyridopyrrolopyrazine dione compounds useful as hiv integrase inhibitors DHPS, DPYD, TYMP AKR1B1 318/4885KCNH2 1318/4885GRM2 4487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.